Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Pharma industry dodges tariff blow but still braces for disruption

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

Latest news

UK life sciences venture capital funding lags behind

At the BioTrinity Conference, experts champion government funding programmes to bridge gaps in UK venture capital financing.

US uncertainty weighs on IPO market while UK innovation could benefit

Panellists at the OBN BioTrinity 2025 conference in London discussed how US uncertainty is impacting the biopharma environment.

ACC 2025: GLP-1RAs may reduce incidence of AF/flutter and stroke in diabetic patients

The study concluded that treatment with SGLT-2I in conjunction with GLP-1RA may help to reduce the incidence of AF/flutter and stroke in T2D patients.

Weight loss implants to increase compliance and cut admin burden for patients

Subdermal implants, changed once or twice per year, could deliver GLP-1R agonist with no need for a weekly injection.

Organon acquires Actemra biosimilar’s US rights from Biogen

Bio-Thera Solutions, the developer of the biosimilar, will continue to hold manufacturing rights in the US market.

FDA grants accelerated approval to Novartis’ Vanrafia for IgAN

The approval is supported by a prespecified interim analysis from the ongoing, randomised Phase III ALIGN trial.

Astellas Pharma and JFCR partner for oncology research

The agreement stipulates that projects will be co-selected, drawing on shared interests and areas of expertise.